drugset / Trial / NCT07505069
Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors
NaSingle-groupOpen-labelDiagnostic
Summary
RT01-89Zr is a TF-targeting radiopharmaceutical diagnostic agent. This trial aims to evaluate the safety, biodistribution, dosimetry, and imaging characteristics of RT01-89Zr as a PET/CT tracer in patients with malignant solid tumors that highly express the TF target.
Timeline
- Start
- 2026-01-29
- Primary completion
- 2026-12-30
- Completion
- 2027-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RT01-89Zr | Diagnostic / imaging agent | 37 mbq | Intravenous |
| Subject | RT01-89Zr | Diagnostic / imaging agent | 74 mbq | Intravenous |